2025-04-08 18:21:04
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Gufic Biosciences Ltd Q4 FY22 net profit at Rs. 20.26 crores
Posted On : 2022-05-20 22:35:32( TIMEZONE : IST )
Gufic Biosciences Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 162.2338 crores during the period ended March 31, 2022 as compared to Rs. 173.5957 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 20.2642 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 21.0326 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 2.09 for the period ended March 31, 2022 as compared to Rs. 2.17 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 162.2338 crs | ₹173.5957 crs |  -6.55% |
| Net Profit | ₹20.2642 crs | ₹21.0326 crs | -3.65% |
| EPS | ₹2.09 | ₹2.17 | -3.69% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 162.2338 crores during the period ended March 31, 2022 as compared to Rs.132.5849 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.20.2642 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.12.8704 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.2.09 for the period ended March 31, 2022 as compared to Rs.1.33 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 162.2338 crs | ₹132.5849 crs |  22.36% |
| Net Profit | ₹20.2642 crs | ₹12.8704 crs | 57.45% |
| EPS | ₹2.09 | ₹1.33 | 57.14% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.782.2598 crores during the Financial Year ended March 31, 2022 as compared to Rs.491.4316 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.95.8401 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.44.2316 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.9.89 for the Financial Year ended March 31, 2022 as compared to Rs.4.56 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹782.2598 crs | ₹491.4316 crs | 59.18% |
| Net Profit | ₹95.8401 crs | ₹44.2316 crs | 116.68% |
| EPS | ₹9.89 | ₹4.56 | 116.89% |
Shares of Gufic Biosciences Limited was last trading in BSE at Rs. 244.50 as compared to the previous close of Rs. 243.00. The total number of shares traded during the day was 13483 in over 1203 trades.
The stock hit an intraday high of Rs. 250.65 and intraday low of 235.70. The net turnover during the day was Rs. 3266453.00.
